Study Sheds Light On Impact Of Intramural Leiomyomas On Fertility: Size Matters, Removal Offers No Benefit
- byDoctor News Daily Team
- 08 July, 2025
- 0 Comments
- 0 Mins
USA: A recent systematic review and meta-analysis have delved into the relationship between intramural leiomyomas-commonly known as fibroids-and fertility, shedding light on implications for women's reproductive health. Published in Obstetrics & Gynecology, the study synthesized findings from numerous research studies to elucidate how these benign uterine growths impact fertility outcomes.
The study found lower fertility rates for women with intramural leiomyomas and women with more than one leiomyoma in any location. The removal of leiomyoma does not improve outcomes.
Intramural leiomyomas are non-cancerous tumors that develop within the muscular wall of the uterus. They are prevalent among women of reproductive age and can vary significantly in size and number. Concerns often arise regarding their potential interference with conception and pregnancy outcomes.
Against the above background, Elizabeth A. Pritts, Wisconsin Fertility Institute, Madison, WI, and colleagues aimed to evaluate fertility outcomes based on the size and number of intramural leiomyomas and outcomes after removal.
For this purpose, the researchers searched the online databases from 1994 to 2023. A total of 5,143 studies were identified, with the inclusion of 13 study groups. The study provided data on the size and number of leiomyomas, correlating these findings with clinical pregnancy rates and rates of ongoing pregnancies or live births.
The following were the key findings of the study:
In data sets with maximum leiomyoma diameters of less than 6 cm for study inclusion, women with leiomyomas smaller than 3 cm had lower clinical pregnancy rates than women without leiomyomas, with an odds ratio (OR) of 0.53 and, for ongoing pregnancy or live-birth rates, an OR of 0.59.
The ORs for clinical pregnancy rates in women with intermediately-sized leiomyomas (those between 3 cm and 6 cm) were lower than in women without leiomyomas, with an OR at 0.43 and, for ongoing pregnancy or live-birth rates, an OR at 0.38.
In data sets without exclusion for women with larger-sized leiomyomas, clinical pregnancy rates were lower for those with leiomyomas smaller than 5 cm compared with those without leiomyomas, with an OR of 0.75.
Women with leiomyomas larger than 5 cm showed no differences in clinical pregnancy rate compared with women without leiomyomas, with an OR of 0.71.
Although women with a single leiomyoma in any location had no differences in outcomes, those with more than one leiomyoma had lower clinical pregnancy rates and ongoing pregnancy or live birth rates, with an OR of 0.62 and 0.57, respectively.
The clinical pregnancy rate for women undergoing myomectomy for intramural leiomyomas was no different than those with intramural leiomyomas in situ, with an OR of 1.10.
"The findings imply that even small intramural leiomyomas are linked with lower fertility; removal does not confer benefit. Women with more than one leiomyoma in any location have lower fertility," the researchers concluded.
Reference:
Pritts TL, Ogden M, Parker W, Ratcliffe J, Pritts EA. Intramural Leiomyomas and Fertility: A Systematic Review and Meta-Analysis. Obstet Gynecol. 2024 Jun 27. doi: 10.1097/AOG.0000000000005661. Epub ahead of print. PMID: 38935974.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
Eli Lilly plans to build new USD 3 billion facilit...
- 04 November, 2025
Rajkot Maternity Hospital CCTV Leak: How a simple...
- 04 November, 2025
Gland Pharma profit rises 12 percent to Rs 184 cro...
- 04 November, 2025
AIIMS Delhi doctors told to use Hindi in prescript...
- 04 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!